Thirumalai Chemicals Reports Q3FY26 Net Loss of ₹2,742 Lakhs Amid Revenue Decline

2 min read     Updated on 14 Feb 2026, 04:45 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Thirumalai Chemicals Limited reported a standalone net loss of ₹2,742 lakhs in Q3FY26 compared to a profit of ₹1,845 lakhs in Q3FY25, with revenue declining 39.7% to ₹30,027 lakhs. Consolidated performance was also weak with a net loss of ₹4,657 lakhs. The company announced the resignation of Independent Director Mr. Arun Alagappan effective March 31, 2026, and appointed Mr. K. Anand Kumar as President-Finance. The subsidiary TCL Specialties LLC commenced commissioning of its Maleic Anhydride plant in December 2025.

32613303

*this image is generated using AI for illustrative purposes only.

Thirumalai Chemicals Limited announced its unaudited financial results for the quarter ended December 31, 2025, showing a significant decline in performance compared to the previous year. The company reported substantial losses on both standalone and consolidated basis, marking a challenging quarter for the specialty chemicals manufacturer.

Financial Performance Overview

The company's standalone financial performance showed a marked deterioration during Q3FY26. Revenue from operations declined substantially, while the company moved from profitability to losses compared to the same quarter in the previous fiscal year.

Metric: Q3FY26 Q3FY25 Change
Revenue from Operations: ₹30,027 lakhs ₹49,826 lakhs -39.7%
Other Income: ₹720 lakhs ₹528 lakhs +36.4%
Total Income: ₹30,747 lakhs ₹50,354 lakhs -39.0%
Net Profit/(Loss): (₹2,742 lakhs) ₹1,845 lakhs Loss

Consolidated Results

On a consolidated basis, the company's performance was even more challenging, with higher losses reported across key metrics. The consolidated revenue also witnessed a significant decline year-on-year.

Parameter: Q3FY26 Q3FY25 Variance
Consolidated Revenue: ₹41,585 lakhs ₹44,665 lakhs -6.9%
Consolidated Net Loss: (₹4,657 lakhs) ₹4,202 lakhs Loss
Total Comprehensive Loss: (₹1,826 lakhs) ₹2,816 lakhs -

Nine-Month Performance

For the nine months ended December 31, 2025, the standalone revenue from operations was ₹1,10,278 lakhs compared to ₹1,57,386 lakhs in the corresponding period of FY25. The company reported a standalone net loss of ₹5,457 lakhs for the nine-month period versus a profit of ₹4,470 lakhs in the previous year.

Leadership Changes

The company announced significant changes in its leadership structure during the board meeting held on February 14, 2026.

Director Resignation

Mr. Arun Alagappan tendered his resignation as Independent Director, effective from the closure of business hours on March 31, 2026. He cited increased professional commitments and demands at his own organization where he holds an executive role as the reason for resignation.

New Appointment

Mr. K. Anand Kumar has been appointed as President-Finance and designated as Senior Management Personnel effective February 14, 2026. He is an Associate Member of the Institute of Chartered Accountants of India (ICAI) and the Institute of Cost Accountants of India (ICMAI), and holds an Executive MBA from IIM Bangalore with over 24 years of experience across diverse industries.

Operational Updates

TCL Specialties LLC, USA, a step-down wholly owned subsidiary of Thirumalai Chemicals Limited, commenced the phased commissioning of its Maleic Anhydride plant in December 2025. The phased commissioning process is expected to be completed and stabilized progressively during the first half of calendar year 2026.

Recent Capital Raising

The company had undertaken preferential issues during FY26, allotting 1,62,68,040 equity shares on August 26, 2025, at ₹277 per share aggregating to ₹45,062 lakhs, and 18,96,614 equity shares on December 23, 2025, at ₹296 per share aggregating to ₹5,614 lakhs.

Historical Stock Returns for Thirumalai Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.15%+5.93%-4.19%-27.05%-16.59%+110.09%

ICRA Downgrades Thirumalai Chemicals Credit Ratings to BBB+ (Negative) on Performance Concerns

2 min read     Updated on 13 Jan 2026, 06:35 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

ICRA Limited has downgraded Thirumalai Chemicals Limited's credit ratings to [ICRA]BBB+ (Negative) for long-term instruments and [ICRA]A2 for short-term facilities across debt instruments worth ₹1,317.55 crores. The downgrade affects working capital facilities, term loans, and non-convertible debentures, with ICRA citing performance moderation and increased US project costs as key factors. The company has informed stock exchanges about this rating action in compliance with SEBI regulations.

29855142

*this image is generated using AI for illustrative purposes only.

Thirumalai Chemicals Limited has received a credit rating downgrade from ICRA Limited, with the rating agency revising its assessment across multiple debt instruments totaling ₹1,317.55 crores. The company informed the stock exchanges on January 13, 2026, about the rating action communicated by ICRA on January 12, 2026.

Rating Downgrade Details

ICRA has downgraded the company's credit ratings to [ICRA]BBB+ (Negative) for long-term instruments and [ICRA]A2 for short-term facilities. The rating agency cited moderation in the company's performance and increase in US project costs as the primary reasons for this downgrade.

Instrument Type Amount (₹ crores) New Rating Previous Status
Long-term Fund-based Working Capital 480.50 [ICRA]BBB+ (Negative) Downgraded
Long-term Fund-based Term Loan 437.05 [ICRA]BBB+ (Negative) Downgraded
Long-term/Short-term Unallocated Limits 200.00 [ICRA]BBB+ (Negative)/[ICRA]A2 Downgraded
Short-term Non-fund Based Facilities 100.00 [ICRA]A2 Downgraded
Short-term Non-fund Based Facilities (Sublimits) 680.00 [ICRA]A2 Downgraded
Non-convertible Debentures 100.00 [ICRA]BBB+ (Negative) Downgraded
Total Rated Amount 1,317.55

Facility-wise Breakdown

The downgrade encompasses various banking facilities across multiple lenders. The term loans of ₹437.05 crores are distributed among IDFC FIRST Bank Limited (₹212.05 crores), Federal Bank Limited (₹200.00 crores), and CSB Bank Limited (₹25.00 crores). The fund-based working capital facilities of ₹480.50 crores include limits with Axis Bank Limited (₹150.00 crores), IDFC FIRST Bank Limited (₹180.00 crores), ICICI Bank Limited (₹150.00 crores), and Federal Bank Limited (₹0.50 crores).

Non-Convertible Debentures Impact

The rating downgrade also affects the company's non-convertible debentures program worth ₹100.00 crores. The debentures are distributed across three ISIN codes: INE338A07021 (₹33.00 crores), INE338A07013 (₹33.00 crores), and INE338A07039 (₹34.00 crores). All these instruments now carry the [ICRA]BBB+ (Negative) rating.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by informing both BSE Limited and National Stock Exchange of India Limited about the rating action. The communication was signed by Company Secretary Aditya Sharma and submitted to the exchanges with the company's scrip codes 500412 (BSE) and TIRUMALCHM (NSE).

Rating Surveillance and Future Reviews

ICRA has indicated that the ratings will become due for surveillance within one year from the date of the rating communication. The rating agency reserves the right to review and revise the ratings at any time based on new information or circumstances that could impact the company's creditworthiness. Investors and lenders are advised to visit ICRA's website for the latest rating updates on the company.

Historical Stock Returns for Thirumalai Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.15%+5.93%-4.19%-27.05%-16.59%+110.09%

More News on Thirumalai Chemicals

1 Year Returns:-16.59%